Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis

References

• Saraiva MJ, Costa PP, Goodman DS. Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy. Neurology 1986;36:1413–17
   PubMed Web of Science ®Google Scholar
• Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54–69
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;34:1113–16
   Google Scholar
• Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Planté V, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123:1495–504
   PubMed Web of Science ®Google Scholar
• Cavallaro T, Martone RL, Dwork AJ, Schon EA, Herbert J. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci 1990;31:497–501
   PubMed Web of Science ®Google Scholar
• Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, Inomata Y, et al. Transthyretin synthesis in ciliary pigment epithelium. Exp Eye Res 2005;81:306–12
   PubMed Web of Science ®Google Scholar
• Ando E, Ando Y, Haraoka K. Ocular amyloid involvement after liver transplantation for polyneuropathy. Ann Intern Med 2001;135:931–2
   PubMed Web of Science ®Google Scholar
• Munar-Qués M, Salva-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraiva MJ. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 2000;7:266–9
   PubMed Web of Science ®Google Scholar
• Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173–96
   PubMed Web of Science ®Google Scholar
• Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295–8
   PubMed Web of Science ®Google Scholar
• Kimura A, Ando E, Fukushima M, Koga T, Hirata A, Arimura K, Ando Y, et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch Ophthalmol 2003;121:351–6
   PubMedGoogle Scholar
• Takei Y, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Ando Y; Japanese Liver Transplantation Society. Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations. Intern Med 2005;44:1151–6
   PubMed Web of Science ®Google Scholar
• Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, Suga M, et al. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 1995;345:195–6
   PubMed Web of Science ®Google Scholar
• Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 2008;86:520–4
   PubMed Web of Science ®Google Scholar
• Haraoka K, Ando Y, Ando E, Sun X, Nakamura M, Terazaki H, Misumi S, et al. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid 2002;9:247–51
   PubMed Web of Science ®Google Scholar
• Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996;62:1037–8
   PubMed Web of Science ®Google Scholar
• Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol 2010;128:206–10
   PubMedGoogle Scholar
• Rousseau A, Kaswin G, Adams D, Cauquil C, Théaudin M, Mincheva Z, M'garrech M, et al. Ocular involvement in familial amyloid polyneuropathy. J Fr Ophtalmol 2013;36:779–88
   PubMed Web of Science ®Google Scholar
• Beirão JM, Moreira LV, Lacerda PC, Vitorino RP, Beirão IB, Torres PA, Costa PP. Inability of mutant transthyretin V30M to cross the blood-eye barrier. Transplantation 2012;94:e54–6
   PubMed Web of Science ®Google Scholar
• Martinho A, Gonçalves I, Costa M, Santos CR. Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors. J Mol Neurosci 2012;48:1–13
   PubMedGoogle Scholar
• Maitchouk DY, Beuerman RW, Ohta T, Stern M, Varnell RJ. Tear production after unilateral removal of the main lacrimal gland in squirrel monkeys. Arch Ophthalmol 2000;118:246–52
   PubMed Web of Science ®Google Scholar
• Obayashi K, Ando Y. Focus on autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 2012;19:28–9
   PubMed Web of Science ®Google Scholar
• Sandgren O, Ericsson A. Lacrimal dysfunction in familial amyloidotic polyneuopathy (FAP), Swedish type. Arquivos de Medicina 1990;3:329–33
   Google Scholar
• Chung CW, Tigges M, Stone RA. Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci 1996;37:238–45
   PubMed Web of Science ®Google Scholar